Cultivated autologous limbal epithelial cells (CALEC) transplant, in which stem cells from the healthy eye and transplanted into the injured eye, for significant cornea injuries was found safe and led to gains in preliminary phase I clinical trial.
Microwaving hard-boiled eggs is one of the latest TikTok trends that can harm your eyes
In Physics of Fluids, Vega et al. researched human tears at the micron level to reveal new ways of customizing artificial tears to address individual symptoms of dry eye disease. The detailed insights they gained about the composition and behavior of tears could also apply to the study of ocular pathogens as well as other biological fluids. The authors collected healthy human tears and tested 10 different formulations of artificial tears and applied microrheology methods using dynamic light scattering.
Researchers at Wilmer Eye Institute, Johns Hopkins Medicine say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. The results are from a study that used mouse as well as human retinal organoids and eye cell lines.
Cedars-Sinai investigators have produced the most extensive analysis to date of changes in the retina—a layer of tissue at the back of the eye where visual information originates—and how those retinal changes correspond to brain and cognitive changes in Alzheimer’s disease patients.
Two separate eye diseases may contribute to age-related macular degeneration (AMD), a leading cause of blindness in the United States, according to a new study from New York Eye and Ear Infirmary of Mount Sinai.
An international team of researchers led by Mass Eye and Ear discovered a new genetic mutation that leads to childhood glaucoma, and in the process uncovered a new mechanism for causing the disease.
In this study of 3,000 adults with cataracts, the risk of developing dementia was lower in participants who underwent cataract removal compared with those who didn’t.
A new laser-activated nanoparticle promises to target and destroy eye cancer cells and preserve vision.
New research confirms that increased screen time did lead to more eye strain in children, as well as a more troubling eye condition called convergence insufficiency, which can cause difficulty reading.
Using data generated from patients and mice with genetic mutation for the disorder Usher syndrome, researchers from the University of Maryland School of Medicine and the National Institutes of Health documented the natural history of vision impairment in patients and identified the cell mechanism behind progressive vision loss.
An international team of researchers has broadened and deepened understanding of how inherited retinal dystrophies (IRDs) affect different populations of people and, in the process, have identified new gene variants that may cause the diseases.
IAFNS-supported review focuses on carotenoid intake impact on a key aspect of eye health.
Researchers at the National Institutes of Health have discovered that decisions based on visual information, which involve a complex stream of data flowing forward and backwards along the brain’s visual pathways, is broadcast widely to neurons in the visual system, including to those that are not being used to make the decision.
With the National Eye Institute reporting that about 11 million older adults in the U.S. endure a condition that leads to progressive blindness, known as age-related macular degeneration, University of Maryland School of Medicine (UMSOM) researchers are starting to understand what goes wrong in the disease, in order to develop new therapies to treat it.
New advances by medical researchers and engineers at the University of Wisconsin–Madison may provide hope for those suffering from vision loss.
A recently announced initiative from the American Academy of Ophthalmology to protect children from the vision-threatening consequences of high myopia (nearsightedness) has attracted major financial support from CooperVision.
Researchers at UC San Diego Health see a possible way to detect heart disease through the eye.
A newly developed light-sensing protein called the MCO1 opsin restores vision in blind mice when attached to retina bipolar cells using gene therapy. The National Eye Institute, part of the National Institutes of Health, provided a Small Business Innovation Research grant to Nanoscope, LLC for development of MCO1. The company is planning a U.S. clinical trial for later this year.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
